Document is current

Any future updates will be listed below

Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s12032-015-0704-x

Published Online: 2015-10-23

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark